Synthesis of N-arylidene-2-(2-Phenoxyphenyl) acetohydrazides as anti-inflammatory agents

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 369-377

  Shekarchi, Maral ^a   Navidpour, Latifeh ^b   Khoramia, Afshin Rajabi ^a   Shekarchi, Mahtab ^b   Partoazar, Alireza ^b   Shafaroodi, Hamed ^c   Rahmanipour, Narges ^b   Shafiee, Abbas ^b   Shekarchi, Maryam ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Anti inflammatory activity; N acylhydrazones; N arylidene 2 (2 phenoxyphenyl) acetohydrazide derivatives; Non steroidal anti inflammatory drugs

Indexed keywords

2 (2 PHENOXYPHENYL) ACETOHYDRAZIDE; ACETOHYDRAZIDE; BENZOIC ACID DERIVATIVE; CARRAGEENAN; DICLOFENAC; HYDRAZIDE DERIVATIVE; N (2, 4 DIMETHOXYBENZYLIDENE) 2 (2 PHENOXYPHENYL) ACETOHYDRAZIDE; N (3,4,5 TRIMETHOXYBENZYLIDENE) 2 (2 PHENOXYPHENYL) ACETOHYDRAZIDE; N (4 CHLOROBENZYLIDENE) 2 (2 PHENOXYPHENYL) ACETOHYDRAZIDE; N (4 METHYL BENZYLIDENE) 2 (2 PHENOXYPHENYL) ACETOHYDRAZIDE; N BENZYLIDENE 2 (2 PHENOXYPHENYL)ACETOHYDRAZIDE; NICOTINIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; GASTROINTESTINAL TOXICITY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAW EDEMA; QUALITATIVE ANALYSIS; RAT; STRUCTURE ACTIVITY RELATION;

EID: 84867776789     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lipsy P. The role of cyclooxygenase-2-specific-inhibitors in clinical practice. Am. J. Med. (2001) 110: 1S-5S.
2. Palomer A, Cabre F, Pascual J, Campos J, Trujillio MA, Entrena A, Gallo MA, Garcia L, Mauleon D, Espinosa A. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J. Med. Chem. (2002) 45: 1402-1411.
3. Talley JJ, Brown DL, Carter JS, Graneto MJ, Koboldt CM, Masferrer JL, Perkins WE, Rogers RS, Shaffer AF, Zhang YY, Zweifel BS, Seibert K. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J. Med. Chem.(2000) 43: 775-777.
4. Cryer B. NSAIDs and Risks. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality. Am. J. Gastroenterol. (2005) 100: 1685-1693.
5. Go MF. Drug injury in the upper gastrointestinal tract: non-steroidal anti-inflammatory drugs. Gastrointest. Endosc. Clin. N. Am. (2006) 16: 83-97.
6. James MW and Hawkey JH. Assessment of non- steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract. J. Clin. Pharmacol. (2003) 56: 146-155.
7. Lazzaroni M and Porro GB. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment. Pharmacol. Ther (2004) 20: 48-58.
8. Schneider V, Levesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am. J. Epidemiol. (2006) 164(9):881-9.
9. Adebayo D and Bjarnason I. Is non-ste roidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad. Med. J. (2006) 82: 186-191.
10. Chiroli V, Benedini F, Ongini E and Del Soldato P. Nitric oxide-donating non-steroidal antiinflammatory drugs. Eur. J. Med. Chem. (2003) 38: 441-446.
11. Corazzi T, Leone M, Maucci R, Corazzi L and Gresele P. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). J. Pharmacol. Exp. Ther. (2005) 315: 1331-1337.
12. 2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies. Bioorg. Med. Chem. (2007) 15: 4767-4774.
13. Downing JEG, Madden JC, Ingram MJ and Rostron C. Gastric and thymic assay of acute oral treatment of rats with nitric oxide esters of ibuprofen or indomethacin. Biochem. Biophys. Res. Commun. (2005) 334: 646-653.
14. Duarte CD, Tributino JL, Lacerda D, Martins MV, Moreira AM, Dutra F, Bechara EJ, Paula FS, Goulart MO, Ferreira J, Calixto JB, Nunes MP, Bertho AL, Miranda ALP, Barreiro E and Fraga CA. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg. Med. Chem. (2007) 15: 2421-2433.
15. Figueiredo JM, Camara CA, Amarante EG, Miranda ALP, Santos FM, Radrigues CR, Fraga CA and Barreiro EJ. Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylharazone derivatives. Bioorg. Med. Chem. (2000) 8: 2243-2248.
16. Almasirad A, Tajik M, Bakhtiari D, Shafiee A, Abdollahi M, Zamani MJ, Khorasani R and Esmaily H. Synthesis and analgesic activity of N-Arylhydrazone derivatives of mefenamic acid. J. Pharm. Pharm. Sci. (2005) 8: 419-425.
17. Almasirad A, Hosseini R, Jalalizadeh H, Rahimi-Moghaddam Z, Abaeian N, Janafrooz M, Abbaspour M, Ziaee V, Dalvandi A and Shafiee A. Synthesis and analgesic activity of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides. Biol. Pharm. Bull. (2006) 29: 1180-1185.
18. Al-Haboubi HA and Zeitlin IJ. Re-appraisal of the role of histamine in carrageenan-induced paw oedema. Eur. J. Pharmacol. (1983) 88: 169-176.
19. Perez MM, Docampo RM, Puigmarti Codina JM, Repolles-Moliner J and Sola JS. (1986) U.S. Pat. Appl. US 4623648.
20. Pirkle WH and Beare SD. Optically active solvents in nuclear magnetic resonance spectroscopy. IX. Direct determinations of optical purities and correlation of absolute configuration of a-amino acids. J. Am. Chem. Soc. (1969) 91: 5150-5155.
21. Firoozi F, Javidnia F, Kamal M, Fooladi M, Forumadi A, Shafiee A, Synthesis of substituted 1-methy 1-2-(1,3,4-thiadiazol-2-yl)-4-nitropyrroles. J. Heterocycl. Chem. (1995) 32: 123-128.
22. Kamal A, Khan MN, Reddy KS and Rohini K Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents. Bioorg. Med. Chem. (2007) 15: 1004-1013.
23. Ribeiro IG, Silva KCM, Parrini SC, Miranda ALP, Fraga CAM and Barreiro E. Synthesis and antinociceptive properties of new structurally planned imidazo[1,2-a] pyridine 3-acylarylhydrazone derivatives. Eur. J. Med. Chem. (1998) 33: 225-235.
24. Figueiredo JM, Câmara CA, Amarante EG, Miranda AL, Santos FM, Rodrigues CR, Fraga CA and Barreiro EJ. Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylarylhydrazones derivatives. Bioorg. Med. Chem. (2000) 8: 2243-2248.
25. Cunha AC, Figueiredo JM, Tributino JL, Miranda AL, Castro HC, Zingali RB, Fraga CA, Souza MC, Ferreira VF and Barreiro EJ. Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone. Bioorg. Med. Chem. (2003) 11: 2051-205.